DHX37 and thyroid gland carcinoma: DHX37 overexpression was related to poor outcomes of OS (overall survival) and DFS (disease-free survival) in ACC (adrenocortical carcinoma), LGG (brain lower grade glioma), and LIHC (liver hepatocellular carcinoma); OS in LUAD (lung adenocarcinoma), MESO (mesothelioma), and THCA (thyroid carcinoma); and DFS (disease-free survival) in SKCM (Skin Cutaneous Melanoma).